[ WEEKLY GXP BRIEFING ]

What changed in GxP, one Monday at a time.

One item that mattered, the comment windows still open, and a windowed sweep across FDA, EMA, MHRA and Health Canada — with SPEQ’s reading kept visibly separate from the regulator’s facts.

How to use this library

Every Weekly GxP Briefing that has been sent, newest first. Search the subject and opening line to find the week something happened, then open an issue to read it in full.

Each issue is reproduced as it was sent. It reflects what was known at the time of sending and is not updated afterwards — follow the regulator links inside it for the current position.

New to GxP? Start with Navigator →

3 issues

Newest first

No. 43FDA finalizes , and a comment window closing in 0 days1 MHRA alert · 5 Health Canada recalls · 3 new final FDA guidances2026-10-26

No. 42FDA finalizes Blood, Blood Products, and a comment window closing in 0 days1 EU GMP non-compliance report · 4 MHRA alerts · 11 Health Canada recalls · 2 new final FDA guidances2026-10-19

No. 41FDA finalizes Biosimilars, and a comment window closing in 1 day4 EU GMP non-compliance reports · 4 MHRA alerts · 13 Health Canada recalls · 3 new final FDA guidances2026-10-12

COMPLETE INDEX — ALL 3 ISSUE

Every count on this page is derived from the briefing_issues table at render — none is a literal.